Ameridose and Alaunus Pharmaceutical, sister companies of the New England Compounding Center, will cease operations following the meningitis outbreak caused by steroid injections made at NECC, according to a Reuters report.
As of Oct. 8, the CDC reported a total 105 meningitis cases, including eight deaths, in connection to contaminated steroid injections prepared by NECC. The steroid injections have since been recalled, the state of Massachusetts is requiring all compounding pharmacies to acknowledge they are following regulations on compounding medications, according to the report.
Alaunus, Ameridose and NECC are all owned by engineer Gregory Conigliaro and pharmacist Barry Cadden.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
As of Oct. 8, the CDC reported a total 105 meningitis cases, including eight deaths, in connection to contaminated steroid injections prepared by NECC. The steroid injections have since been recalled, the state of Massachusetts is requiring all compounding pharmacies to acknowledge they are following regulations on compounding medications, according to the report.
Alaunus, Ameridose and NECC are all owned by engineer Gregory Conigliaro and pharmacist Barry Cadden.
More Articles on Patient Safety:
Patient Safety Tool: MRSA Prevention Patient Education
6 Key Infection Control Best Practices for Inpatient and Outpatient Settings
Hospitals That Cooperate on Infection Control Efforts See Greater Success